Manufacturers and regulators face dilemmas as Europe tries to agree specifications for the IVD (in vitro diagnostics) Directive
This article was originally published in Clinica
Executive Summary
Companies aiming to CE-mark their diagnostics in Europe face a raft of uncertainties that could cause difficulties and additional expense. Amanda Maxwell reports from a Management Forum meeting on the IVD Directive in London last month.